Reference priceKRW ₩381,526.20Original source price: INR 23,551.00. Converted estimates are available by currency selection.
| Brand | Emcure Pharmaceuticals Ltd |
|---|---|
| Manufacturer | Emcure Pharmaceuticals Ltd |
| Prescription required | Yes |
Embremma 0.5mg Injection
Eribulin Mesylate (0.5mg/ml)
Description
Embremma 0.5mg Injection is a chemotherapy drug that contains the active substance eribulin, which belongs to the class of antineoplastic agents. Embremma 0.5mg Injection is used in adults for advanced breast cancer or liposarcoma (a type of cancer originating from fat tissue) when other treatments have stopped working.Benefits
In Metastatic breast cancer Embremma Injection helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. This medicine is used when other medicines have not shown significant improvement and the cancer has spread to other parts as well. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Embremma Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.How to Use
Your doctor or nurse will give you this medicine. Kindly do not self administer.Specification
Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Embremma Anemia (low number of red blood cells) Weakness Hair loss Nausea Constipation Decreased white blood cell count Fatigue Peripheral neuropathy (tingling and numbness of feet and hand)This information is for reference only. Consult a qualified healthcare professional before using any medicine.